BTK-IN-20
Product Specifications
UNSPSC Description
BTK-IN-20 (compound 283) is a BTK tyrosine kinase inhibitor and a 1H-pyrazolo[3,4-d]pyrimidine derivative. BTK-IN-20 can be used for the research of cancer and inflammation[1].
Target Antigen
Btk
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/btk-in-20.html
Solubility
10 mM in DMSO
Smiles
NC1=C(C(C2=CC=C(OC3=CC=CC=C3)C=C2F)=NN4[C@H]5CN(C(/C(C#N)=C\C(C)(C)C)=O)CCC5)C4=NC=N1
Molecular Weight
539.60
References & Citations
[1]Goldstein, David Michael. Preparation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as tyrosine kinase inhibitors. US8673925. 2014.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-148832/BTK-IN-20-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-148832/
Clinical Information
No Development Reported
CAS Number
1581714-50-2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
